|
시장보고서
상품코드
1526393
세계의 포도당 바이오센서 시장 : 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 기술별, 제어 방법별, 최종 용도별, 지역별 정보 예측(2024-2032년)Global Glucose Biosensors Market Size, Share, Trends, Industry Analysis Report: Information By Type (CGM, SMBG ), By Technology, By Control Method, By End-Use, and By Region - Market Forecast, 2024 - 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 세계 포도당 바이오센서 시장 규모는 2032년까지 232억 8,000만 달러에 이를 것으로 예상됩니다. 이 보고서는 현재 시장 역학을 상세하게 인사이트하고 미래 시장 성장에 대한 분석을 제공합니다.
세계적으로 당뇨병의 유병률은 앉기 쉬운 라이프 스타일, 비만, 노화 등의 요인에 의해 증가하고 있습니다. 이 인구 동향은 혈당 수치를 모니터링하고 당뇨병을 효과적으로 관리하는 포도당 바이오 센서의 중요한 필요성을 강조합니다. 보다 정확하고 사용자 친화적인 바이오 센서 개발을 포함한 센서 기술의 끊임없는 혁신은 매력과 채택을 강화하고 있습니다. 연속 포도당 모니터링(CGM) 시스템 및 소형화된 장치와 같은 진보는 포도당 모니터링의 편의성과 정확성을 향상시키고 포도당 바이오센서 시장 수요 촉진에 기여하고 있습니다.
스마트폰 및 기타 디지털 건강 플랫폼과 통합된 포도당 바이오센서는 실시간 모니터링, 데이터 분석 및 원격 환자 관리를 가능하게 합니다. 이 연결성은 환자의 참여와 건강 관리 제공업체의 모니터링을 강화하여 이러한 통합 솔루션에 대한 수요를 촉진합니다.
환자의 불편함을 줄이고 컴플라이언스를 향상시키는 비침습성 또는 저침습성 포도당 모니터링 장비에 대한 선호도가 높아지고 있습니다. 광학 및 웨어러블 바이오센서의 기술 혁신은 침습성이 낮은 모니터링 옵션을 제공함으로써 이러한 수요를 해결합니다.
스마트폰 및 웨어러블 디바이스와 원활하게 통합할 수 있는 지능형 바이오센서의 진화는 환자의 컴플라이언스와 참여도를 향상시켰습니다. 포도당 수준을 지속적으로 모니터링하고 신속하게 피드백을 받는 이 기능은 당뇨병 관리를 변화시키고 환자가 병리학을 효과적으로 조절하는 과정을 단순화했습니다.
포도당 바이오센서에 대한 이러한 수요는 당뇨병의 유병률 증가, 기술 진보, 디지털 건강 플랫폼과의 통합, 비침습적 모니터링 선호, 건강 관리 시스템의 효율화에 의해 추진되고 있으며, 포도당 바이오센서 업계의 주요 기업에게는 종합적으로 견고한 시장 기회를 창출하고 있습니다.
포도당 바이오 센서 시장 보고서 하이라이트
2023년에는 효과적인 당뇨병 관리에 필수적인 포도당 측정에서 높은 감도와 정밀도로 전기화학 바이오센서 부문이 가장 큰 시장 점유율을 차지했습니다.
2023년에 병원 카테고리가 가장 큰 시장 점유율을 차지한 이유는 임상 정확도, 지속적인 모니터링, 병원 시스템과의 통합, 규정 준수, 급성 환자 관리 지원에 대한 요구가 있기 때문입니다.
2023년에는 북미의 포도당 바이오센서 시장이 가장 큰 점유율을 차지했는데, 이는 고급 포도당 바이오센서 기술의 보급을 지원하는 건강 관리 인프라가 발달하고 있기 때문입니다.
아시아태평양은 지속 포도당 모니터링 시스템을 포함한 선진 의료 기술의 채용이 증가하고 있기 때문에 예측 기간 동안 높은 복합 연간 성장률(CAGR)로 성장할 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 포도당 바이오센서 시장 인사이트
- 제어방법의 스냅샷
- 포도당 바이오센서 시장 역학
- 성장 촉진요인과 기회
- 억제요인과 과제
- PESTEL 분석
- 포도당 바이오 센서 시장의 제어 방법의 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 포도당 바이오센서 시장 : 유형별
- 주요 조사 결과
- 소개
- 무수 말레산 이식편 PE
- CGM(지속 혈당 모니터링)
- SMBG(자가혈당 측정)
제6장 세계의 포도당 바이오센서 시장 : 기술별
- 주요 조사 결과
- 소개
- 전기화학 바이오센서
- 광학 바이오 센서
- 기타
제7장 세계의 포도당 바이오센서 시장 : 제어 방법별
- 주요 조사 결과
- 소개
- 화학적
- 물리적
- 생물학적
- 기타
제8장 세계의 포도당 바이오센서 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 병원
- 홈케어
- 진단센터
제9장 세계의 포도당 바이오센서 시장 : 지역별
- 주요 조사 결과
- 소개
- 포도당 바이오센서 시장 평가: 지역별(2019년-2032년)
- 북미
- 북미 : 유형별(2019년-2032년)
- 북미 : 기술별(2019년-2032년)
- 북미 : 제어 방법별(2019년-2032년)
- 북미 : 최종 용도별(2019년-2032년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2019년-2032년)
- 유럽 : 기술별(2019년-2032년)
- 유럽 : 제어 방법별(2019년-2032년)
- 유럽 : 최종 용도별(2019년-2032년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2019년-2032년)
- 아시아태평양 : 기술별(2019년-2032년)
- 아시아태평양 : 제어 방법별(2019년-2032년)
- 아시아태평양 : 최종 용도별(2019년-2032년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2019년-2032년)
- 중동 및 아프리카 : 기술별(2019년-2032년)
- 중동 및 아프리카 : 제어 방법별(2019년-2032년)
- 중동 및 아프리카 : 최종 용도별(2019년-2032년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴 아메리카
- 라틴 아메리카 : 유형별(2019년-2032년)
- 라틴 아메리카 : 기술별(2019년-2032년)
- 라틴 아메리카 : 제어 방법별(2019년-2032년)
- 라틴 아메리카 : 최종 용도별(2019년-2032년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴 아메리카
제10장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 프로파일
- Abbott Laboratories
- ACON Laboratories, Inc.
- Ascenia Diabetes Care
- Biolinq Incorporated
- Dexcom
- F. Hoffmann-La Roche Ltd.
- Lifescan
- Medtronic plc
- PalmSens
- SB Solutions
The global glucose biosensors market size is expected to reach USD 23.28 billion by 2032, according to a new study by Polaris Market Research. The report "Glucose Biosensors Market Size, Share, Trends, Industry Analysis Report, By Type (CGM (Continuous Glucose Monitoring), SMBG (Self-monitoring Blood Glucose)); By Technology; By Control Method; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Globally, diabetes prevalence is increasing due to factors such as sedentary lifestyles, obesity, and aging populations. This demographic trend underscores the critical need for glucose biosensors to monitor blood sugar levels and manage diabetes effectively. Continuous innovation in sensor technology, including the development of more accurate and user-friendly biosensors, enhances their appeal and adoption. Advances such as continuous glucose monitoring (CGM) systems and miniaturized devices improve convenience and accuracy in glucose monitoring and contribute to driving the glucose biosensors market demand.
Glucose biosensors that integrate with smartphones and other digital health platforms enable real-time monitoring, data analysis, and remote patient management. This connectivity enhances patient engagement and healthcare provider oversight, driving demand for these integrated solutions.
There is a rising preference for non-invasive or minimally invasive glucose monitoring devices that reduce patient discomfort and improve compliance. Innovations in optical and wearable biosensors cater to this demand by offering less intrusive monitoring options.
The evolution of intelligent biosensors capable of seamless integration with smartphones and wearable devices has enhanced patient compliance and engagement. This capability to continuously monitor glucose levels and promptly receive feedback has transformed diabetes management, simplifying the process for patients to control their condition effectively.
Such demand for glucose biosensors is propelled by the increasing prevalence of diabetes, technological advancements, integration with digital health platforms, preference for non-invasive monitoring, and healthcare system efficiencies, collectively creating a robust market opportunity for key players in the glucose biosensors industry.
Glucose Biosensors Market Report Highlights
In 2023, the electrochemical biosensor segment held the largest market share due to their high sensitivity and accuracy in glucose measurement, which is crucial for effective diabetes management.
The hospital category accounted for the largest market share in 2023 because of the need for clinical accuracy, continuous monitoring, integration with hospital systems, regulatory compliance, and support for acute patient care.
In 2023, the North American glucose biosensors market held the largest share, due to a well-developed healthcare infrastructure that supports the widespread adoption of advanced glucose biosensor technologies.
The Asia-Pacific region is expected to grow at a significant CAGR during the forecast period due to the rising adoption of advanced medical technologies, including continuous glucose monitoring systems.
The global key market players include Abbott Laboratories, ACON Laboratories, Inc., Ascenia Diabetes Care, Biolinq Incorporated, Dexcom, F. Hoffmann-La Roche Ltd., Lifescan, Medtronic plc, PalmSens, and SB Solutions.
Polaris Market Research has segmented the glucose biosensors market report based on type, technology, control method, end-use, and region:
Glucose Biosensors, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- CGM (Continuous Glucose Monitoring)
- SMBG (Self-monitoring Blood Glucose)
Glucose Biosensors, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Electrochemical Biosensor
- Optical Biosensor
- Others
Glucose Biosensors, Control Method Outlook (Revenue - USD Billion, 2019 - 2032)
- Chemical
- Physical
- Biological
- Others
Glucose Biosensors, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals
- Homecare
- Diagnostic Center
Glucose Biosensors, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia-Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Glucose Biosensors Market Insights
- 4.1. Glucose Biosensors Market - Control Method Snapshot
- 4.2. Glucose Biosensors Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological advancements in glucose monitoring is driving the market growth
- 4.2.1.2. Rising prevalence of diabetes drive the market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory hurdles are hindering the glucose biosensors market
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Glucose Biosensors Market Control Method Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Glucose Biosensors Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 5.3. Maleic Anhydride Grafted PE
- 5.3.1. Global Glucose Biosensors Market, by Maleic Anhydride Grafted PE, by Region, 2019-2032 (USD Billion)
- 5.4. CGM (Continuous Glucose Monitoring)
- 5.4.1. Global Glucose Biosensors Market, by CGM (Continuous Glucose Monitoring), by Region, 2019-2032 (USD Billion)
- 5.5. SMBG (Self-monitoring Blood Glucose)
- 5.5.1. Global Glucose Biosensors Market, by SMBG (Self-monitoring Blood Glucose), by Region, 2019-2032 (USD Billion)
6. Global Glucose Biosensors Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Electrochemical Biosensor
- 6.3.1. Global Glucose Biosensors Market, by Electrochemical Biosensor, by Region, 2019-2032 (USD Billion)
- 6.4. Optical Biosensor
- 6.4.1. Global Glucose Biosensors Market, by Optical Biosensor, by Region, 2019-2032 (USD Billion)
- 6.5. Others
- 6.5.1. Global Glucose Biosensors Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Glucose Biosensors Market, by Control Method
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 7.3. Chemical
- 7.3.1. Global Glucose Biosensors Market, by Chemical, by Region, 2019-2032 (USD Billion)
- 7.4. Physical
- 7.4.1. Global Glucose Biosensors Market, by Physical, by Region, 2019-2032 (USD Billion)
- 7.5. Biological
- 7.5.1. Global Glucose Biosensors Market, by Biological, by Region, 2019-2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Glucose Biosensors Market, by Others, by Region, 2019-2032 (USD Billion)
8. Global Glucose Biosensors Market, by End-Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Glucose Biosensors Market, by Hospitals, by Region, 2019-2032 (USD Billion)
- 8.4. Homecare
- 8.4.1. Global Glucose Biosensors Market, by Homecare, by Region, 2019-2032 (USD Billion)
- 8.5. Diagnostic Center
- 8.5.1. Global Glucose Biosensors Market, by Diagnostic Center, by Region, 2019-2032 (USD Billion)
9. Global Glucose Biosensors Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Glucose Biosensors Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Glucose Biosensors Market - North America
- 9.3.1. North America: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.3.2. North America: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.3.3. North America: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.3.4. North America: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.3.5. Glucose Biosensors Market - U.S.
- 9.3.5.1. U.S.: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.3.6. Glucose Biosensors Market - Canada
- 9.3.6.1. Canada: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4. Glucose Biosensors Market - Europe
- 9.4.1. Europe: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.2. Europe: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.3. Europe: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.4. Europe: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.5. Glucose Biosensors Market - UK
- 9.4.5.1. UK: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.6. Glucose Biosensors Market - France
- 9.4.6.1. France: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.6.2. France: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.6.3. France: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.6.4. France: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.7. Glucose Biosensors Market - Germany
- 9.4.7.1. Germany: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.8. Glucose Biosensors Market - Italy
- 9.4.8.1. Italy: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.9. Glucose Biosensors Market - Spain
- 9.4.9.1. Spain: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.10. Glucose Biosensors Market - Netherlands
- 9.4.10.1. Netherlands: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.11. Glucose Biosensors Market - Russia
- 9.4.11.1. Russia: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.11.2. Russia: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.4.12. Glucose Biosensors Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.4.12.2. Rest of Europe: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.4.12.3. Rest of Europe: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.4.12.4. Rest of Europe: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5. Glucose Biosensors Market - Asia Pacific
- 9.5.1. Asia Pacific: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.5. Glucose Biosensors Market - China
- 9.5.5.1. China: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.5.2. China: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.5.3. China: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.5.4. China: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.6. Glucose Biosensors Market - India
- 9.5.6.1. India: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.6.2. India: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.6.3. India: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.6.4. India: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.7. Glucose Biosensors Market - Malaysia
- 9.5.7.1. Malaysia: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.7.2. Malaysia: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.7.3. Malaysia: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.7.4. Malaysia: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.8. Glucose Biosensors Market - Japan
- 9.5.8.1. Japan: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.8.2. Japan: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.8.3. Japan: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.8.4. Japan: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.9. Glucose Biosensors Market - Indonesia
- 9.5.9.1. Indonesia: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.10. Glucose Biosensors Market - South Korea
- 9.5.10.1. South Korea: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.11. Glucose Biosensors Market - Australia
- 9.5.11.1. Australia: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.11.2. Australia: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.11.3. Australia: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.11.4. Australia: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.5.12. Glucose Biosensors Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.6. Glucose Biosensors Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.6.5. Glucose Biosensors Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.6.6. Glucose Biosensors Market - UAE
- 9.6.6.1. UAE: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.6.6.2. UAE: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.6.6.3. UAE: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.6.6.4. UAE: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.6.7. Glucose Biosensors Market - Israel
- 9.6.7.1. Israel: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.6.8. Glucose Biosensors Market - South Africa
- 9.6.8.1. South Africa: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.6.8.2. South Africa: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.6.8.3. South Africa: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.6.8.4. South Africa: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.6.9. Glucose Biosensors Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.7. Glucose Biosensors Market - Latin America
- 9.7.1. Latin America: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.7.5. Glucose Biosensors Market - Mexico
- 9.7.5.1. Mexico: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.7.6. Glucose Biosensors Market - Brazil
- 9.7.6.1. Brazil: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.7.7. Glucose Biosensors Market - Argentina
- 9.7.7.1. Argentina: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
- 9.7.8. Glucose Biosensors Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Glucose Biosensors Market, by Type, 2019-2032 (USD Billion)
- 9.7.8.2. Rest of Latin America: Glucose Biosensors Market, by Technology, 2019-2032 (USD Billion)
- 9.7.8.3. Rest of Latin America: Glucose Biosensors Market, by Control Method, 2019-2032 (USD Billion)
- 9.7.8.4. Rest of Latin America: Glucose Biosensors Market, by End-Use, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. ACON Laboratories, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Ascenia Diabetes Care
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Biolinq Incorporated
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Dexcom
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. F. Hoffmann-La Roche Ltd.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Lifescan
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Medtronic plc
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. PalmSens
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. SB Solutions
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
비교리스트